Bullish
Johnson & Johnson's stock rises 1.1% after strong Q2 earnings report
Johnson & Johnson's stock increased by 1.1% following the release of its Q2 2026 earnings report, which exceeded analysts' expectations. The company reported earnings per share (EPS) of $2.90, surpassing the consensus estimate of $2.84, and revenue of $25.31 billion, exceeding the anticipated $25.06 billion.
Key points
- Q2 2026 earnings report shows strong performance, with EPS of $2.90 and revenue of $25.31 billion.
- D.A. Davidson & Co. reduced its stake in Johnson & Johnson by 7.1%, selling 50,822 shares.
- Boston Trust Walden Corp decreased its holdings in Johnson & Johnson by 11.2%, selling 74,565 shares.
Sources
AI-generated from public news sources. Not financial advice.
